Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis

Update Il y a 4 ans
Reference: NCT02559648

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This is a single-site, randomized, placebo-controlled, double blind phase 2b clinical trial. Patients with Thalassemia will participate in this study and will be treated with Denosumab or placebo. The effect of Denosumab on lumbar spine BMD in patients with Thalassemia Major and Osteoporosis will be evaluated as compared with control (placebo) at 12 months.


Inclusion criteria

  • Thalassemia major,Osteoporosis

Links